Valion Bio director Jared Malbin reports no holdings

A new director of Valion Bio, Inc. has filed an initial Form 3 showing no reported holdings or recent insider trades.

Rhea-AI Filing Summary

Valion Bio, Inc. (VBIO) submitted an initial statement of beneficial ownership on Form 3 for Jared David Malbin, who is identified as a director of the company. The Form 3 does not list any equity holdings or report any transactions, and references an accompanying Exhibit 24.1 Power of Attorney.

Key Terms

Power of Attorney

1 terms

Power of Attorney regulatory

"Remarks state: Exhibit 24.1 - Power of Attorney"

A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Valion Bio, Inc. (VBIO) report in this Form 3?

Valion Bio, Inc. reports an initial statement of beneficial ownership for Jared David Malbin as a director. The Form 3 does not list any securities holdings and shows no reportable transactions at this time.

Who is the reporting person in Valion Bio (VBIO)'s Form 3?

The reporting person is Jared David Malbin, who is identified as a director of Valion Bio, Inc. He is not reported as an officer or a ten percent owner in this Form 3.

Does this Valion Bio (VBIO) Form 3 show any insider trades or holdings?

No. The Form 3 shows no reported transactions and no listed holdings of Valion Bio, Inc. securities for Jared David Malbin. The transaction and holding summaries are all zero.

Is there any Rule 10b5-1 trading plan disclosed in this VBIO Form 3?

No Rule 10b5-1 trading plan is reported. The plan status field is null, and there are no footnotes or disclosures indicating trades made under a Rule 10b5-1 or similar trading arrangement.

What additional document is referenced in Valion Bio (VBIO)'s Form 3?

The Form 3 remarks reference Exhibit 24.1 - Power of Attorney, indicating a Power of Attorney is on file authorizing the Form 3 and related actions for the reporting person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/17/2026 - 04:31 PM Accepted by SEC EDGAR 09/17/2026 - 04:30 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Malbin Jared David

(Last) (First) (Middle)

1305 E. HOUSTON STREET

BUILDING 1, SUITE 311

(Street)

SAN ANTONIO TEXAS 78205

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
08/27/2026

3. Issuer Name and Ticker or Trading Symbol
Valion Bio, Inc. [ VBIO ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24.1 - Power of Attorney

No securities are beneficially owned.

	/s/ Jared Malbin	09/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)